NRx Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Business Update
Over the past 12 months, the Company reinitiated its psychiatry development program post pandemic, transferred manufacturing of NRX-101 to the US, and...
Source: prnewswire.com